Skip to main content
. 2022 Sep 6;11(18):5266. doi: 10.3390/jcm11185266

Table 3.

Differences in the magnitude of change from pre- (T1) to post-therapy (T2) results in REH and CON groups.

Test Subtest REH (T2-T1) CON (T2-T1) In-between Comparisons
M SD M SD t/U p
d2 TN 56.69 31.73 34.88 41.09 −1.70 t 0.100
Errors −66.31 24.22 −30.18 39.52 3.14 t 0.004
% Errors −26.08 10.09 −12.51 15.25 3.00 t 0.005
TN-E 123.00 47.52 65.06 66.85 −2.85 t 0.008
CP 43.06 43.72 0.77 43.02 −2.80 t 0.009
FR 43.06 5.98 −0.29 6.98 0.42 t 0.678
CTT CTT-1 −5.00 14.94 −2.86 13.71 0.42 t 0.671
CTT-2 −11.25 27.81 −9.85 34.04 0.16 t 0.875
CTT-II −0.05 0.70 −0.02 0.73 0.14 t 0.893
BCIS BCIS-REF 3.63 5.10 −2.77 6.82 −3.03 t 0.005
BCIS-CER 0.25 4.77 0.41 3.81 125.00 U 0.719
BCIS-INDEX 3.38 3.59 −3.18 7.15 56.00 U 0.004
AIS Total 0.19 9.54 1.53 5.64 0.50 t 0.624
AIS (1–2) −0.38 3.34 0.47 2.32 0.85 t 0.403
AIS (3–8) 0.56 9.04 1.06 4.44 0.20 t 0.841
GSES Total 2.81 8.34 0.41 4.54 118.00 U 0.528
GSES-6 1.44 5.05 0.06 1.44 116.50 U 0.494
NPS (pg/mL) −12.46 15.97 −0.72 9.97 71.00 U 0.020
PANSS Total −4.63 3.40 4.47 10.93 23,50 U 0.000
Positive −1.50 1.26 −0.12 1.32 59,50 U 0.006
Negative −1.44 1.46 1.35 3.06 3.31 t 0.002
General −1.69 2.02 3.24 9.08 23,00 U 0.000

d2—d2 Sustained-Attention Test, TN—total number of letters marked, E—errors, E%—percentage of all errors, TN-E—total number of items processed minus errors, CP—concentration performance, FR –fluctuation rate, CTT—Color Trails Test, CTT-II—Interference Index, BCIS—Beck Cognitive Insight Scale, BCIS-REF—self-reflectiveness subscale, BCIS-CER—self-certainty subscale, AIS—Acceptance of Illness Scale, GSES—General Self-Efficacy Scale, NPS—neuropeptide S, PANSS—Positive and Negative Syndrome Scale, t—Student’s t-test, U—Mann-Whitney U-test.